These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2883903)

  • 1. Convulsions in patients abruptly withdrawn from clonazepam while receiving neuroleptic medication.
    Ghadirian AM; Gauthier S; Wong T
    Am J Psychiatry; 1987 May; 144(5):686. PubMed ID: 2883903
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
    Horiguchi J; Nishimatsu O
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizure in gradual clonazepam withdrawal.
    Wong T; Tiessen E
    Psychiatr J Univ Ott; 1989 Sep; 14(3):484. PubMed ID: 2508139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia, convulsions and neuroleptic malignant syndrome in a male with schizoaffective disorder.
    Looi JC; Cubis JC; Saboisky J
    Aust N Z J Psychiatry; 1995 Dec; 29(4):683-7. PubMed ID: 8825834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizure in gradual clonazepam withdrawal, Vol. 14, No. 3, September, 1989, p. 484.
    Alvarez WA; Zona MA
    Psychiatr J Univ Ott; 1990 Mar; 15(1):64. PubMed ID: 2326391
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
    Eiden C; Capdevielle D; Deddouche C; Boulenger JP; Blayac JP; Peyrière H
    J Addict Med; 2011 Dec; 5(4):302-3. PubMed ID: 21817917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the clinical outcome of patients with profound mental retardation gradually withdrawn from chronic neuroleptic medication.
    May P; London EB; Zimmerman T; Thompson R; Mento T; Spreat S
    Ann Clin Psychiatry; 1995 Dec; 7(4):155-60. PubMed ID: 8721888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent complex partial seizures in a bipolar patient after withdrawal of carbamazepine.
    Garbutt JC; Gillette GM
    J Clin Psychiatry; 1988 Oct; 49(10):410-1. PubMed ID: 3170494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The realities of clonazepam discontinuation.
    Freeman S
    Psychiatr Serv; 1997 Jul; 48(7):881-2. PubMed ID: 9219294
    [No Abstract]   [Full Text] [Related]  

  • 11. Discontinuation of clonazepam in patients with active epilepsy.
    Chataway J; Fowler A; Thompson PJ; Duncan JS
    Seizure; 1993 Dec; 2(4):295-300. PubMed ID: 8162399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic withdrawal.
    Maisami M; Golant D
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):336. PubMed ID: 1673122
    [No Abstract]   [Full Text] [Related]  

  • 13. Imipramine and clonazepam for panic disorder.
    Eppel AB
    Am J Psychiatry; 1989 Feb; 146(2):283-4. PubMed ID: 2912281
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment.
    Perényi A; Frecska E; Bagdy G; Révai K
    Acta Psychiatr Scand; 1985 Nov; 72(5):430-5. PubMed ID: 2868608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysphagia: a rare form of dyskinesia?
    Nieves JE; Stack KM; Harrison ME; Gorman JM
    J Psychiatr Pract; 2007 May; 13(3):199-201. PubMed ID: 17522565
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
    Luchins DJ; Freed WJ; Wyatt RJ
    Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
    Benazzi F
    J Psychopharmacol; 1997; 11(2):190-1. PubMed ID: 9208383
    [No Abstract]   [Full Text] [Related]  

  • 19. Clonazepam: sleep laboratory study of efficacy and withdrawal.
    Kales A; Manfredi RL; Vgontzas AN; Baldassano CF; Kostakos K; Kales JD
    J Clin Psychopharmacol; 1991 Jun; 11(3):189-93. PubMed ID: 2066457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Unwanted drug effects of psychotropic drugs in neurologic practice].
    Schmidt LG; Schüssler G; Linden M; Müller-Oerlinghausen B
    Nervenarzt; 1985 Jan; 56(1):19-24. PubMed ID: 2858064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.